Simplified HCV Screening and Care in People Who Use Drugs
In this episode, Drs. Trooskin and Sulkowski, along with patient advocate Ronni Marks, discuss how to overcome barriers to HCV testing and treatment in the priority population of people who use drugs. Listen as they discuss the strategy of extending care to where people who use drugs are already receiving other services.
Decera Clinical Education Infectious Disease Podcast · Stacey B Trooskin MD PhD MPH, Mark S Sulkowski MD FIDSA FAASLD, Ronni Marks
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics:
- Screening recommendations
- Strategies to improve HCV screening
- HCV testing
- Treatment goals
- Strategies to improve HCV treatment uptake
Presenters:
Stacey B. Trooskin, MD, PhD, MPH
Executive Medical Officer
Mazzoni Center
Faculty, University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania
Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland
Ronni Marks
Founder/Director, The Hepatitis C Mentor and Support Group (HCMSG)
Patient Advocate
New York, New York
Link to full program:
https://bit.ly/4grbwPT
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.